In vitro and in vivo antibiotic susceptibilities of ELB rickettsiae.

Antimicrobial Agents and Chemotherapy
S RadulovicA F Azad

Abstract

The activities of doxycycline, rifampin, chloramphenicol, and erythromycin against ELB rickettsiae (Rickettsia azadi) were determined by dye uptake and plaque assays. Plaque formation in Vero cells was inhibited by 0.12 microgram of doxycycline per ml. The data presented demonstrate the susceptibility of ELB rickettsiae to commonly used antibiotics for the treatment of rickettsial diseases.

References

Jan 11, 1992·Proceedings of the National Academy of Sciences of the United States of America·A F AzadM Carl
Sep 11, 1991·JAMA : the Journal of the American Medical Association·J S DumlerD H Walker
Sep 1, 1984·The American Journal of Tropical Medicine and Hygiene·S Arango-JaramilloC L Wisseman
Apr 1, 1995·The American Journal of Tropical Medicine and Hygiene·K MuraiH Tsubouchi
Sep 1, 1994·Journal of Medical Entomology·M E SchrieferA F Azad
Apr 1, 1994·Journal of Clinical Microbiology·M E SchrieferA F Azad

❮ Previous
Next ❯

Citations

Dec 2, 1977·European Journal of Clinical Pharmacology·P F SonnevilleC M Martin
Jan 1, 1990·Intensive Care Medicine·C C Smith
Nov 1, 2003·Applied Microbiology and Biotechnology·J Spízek, T Rezanka
May 1, 1993·Trends in Pharmacological Sciences·R YarchoanS Broder
Jun 1, 1993·Immunology Today·R YarchoanS Broder
Oct 31, 2008·Talanta·F BelalA M Al-Obaid
May 1, 1997·International Journal of Antimicrobial Agents·H Monteil, C Harf-Monteil
Mar 16, 2000·International Journal of Antimicrobial Agents·J M López-LozanoM Saez
Dec 21, 2000·Trends in Microbiology·S McOrist
Mar 16, 2001·Bioorganic & Medicinal Chemistry·S BounagaM I Page
Sep 29, 2005·Hematology·Vladimir Krcmery, Pavol Beno
Sep 1, 1979·European Journal of Biochemistry·S PerzynskiJ Davies
May 1, 1972·Acta paediatrica Scandinavica·J B AndersenR Vejlsgaard
Jun 4, 2010·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Shinji HidakaYoshiharu Machida
May 30, 2008·PloS One·Pierre-Edouard FournierDidier Raoult
Oct 30, 2003·Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians·Manuel Chirino-TrejoFei Huang
Oct 25, 2013·The ISME Journal·Thibault StalderMarie-Cécile Ploy
Sep 15, 2000·Clinical Chemistry and Laboratory Medicine : CCLM·M C PloyF Denis
May 23, 2012·Journal of Medicinal Chemistry·Kalyan Das
Feb 21, 2002·Current Infectious Disease Reports·Ethan Rubinstein, Itzhak Levi
Nov 21, 2001·Pharmacotherapy·R L White
Jul 1, 1997·European Journal of Drug Metabolism and Pharmacokinetics·H K JonesD Webb
Jul 13, 2000·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·T KameiH Tomioka
Jul 1, 1996·Nature Biotechnology·K M HahnenbergerS Kurtz
Jul 18, 2002·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Stefano MorabitoAlessandra Carattoli
Jul 18, 2002·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·D G WhiteC DebRoy
May 14, 2004·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Cheol-In KangKang-Won Choe
May 14, 2004·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Amy GassamaMarie-Cecile Ploy
May 14, 2004·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·T S EdringtonD J Nisbet
Mar 17, 2005·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Adrienne T A BoxAd C Fluit
Dec 20, 2005·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Engeline Van DuijkerenAd C Fluit
Aug 23, 2006·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Ana Paula D'Alincourt CarvalhoElizabeth de Andrade Marques
Jan 18, 2007·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Rebecca O'MahonySéamus Fanning
Jun 1, 2007·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Alessandra GiordanoAlessandra Carattoli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.